Physician profile
Rajeev Singh
NPI 1225094956
$21,305.98
in general payments reported to CMS, 2019-2025
30 companies · $2,649 in 2025
The $2,649 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,048 · 2020: $2,127 · 2021: $3,496 · 2022: $3,108 · 2023: $4,449 · 2024: $2,429 · 2025: $2,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,738 · Travel and Lodging: $1,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,737.60 |
| Travel and Lodging | $1,788.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,835.13 | 2019-2025 | Aveir, Gallant, Cardiomems |
| W. L. Gore & Associates, INC. | $2,622.75 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Boston Scientific Corporation | $2,579.10 | 2019-2025 | Watchman Access System, Watchman Flx, Baylis Medical Company Radiofrequency Puncture Generator |
| Medtronic Vascular, INC. | $2,151.15 | 2019-2020 | |
| Penumbra, INC. | $1,728.76 | 2019-2023 | Indigo System |
| Biosense Webster, INC. | $1,597.94 | 2019-2025 | Carto 3 |
| Bard Peripheral Vascular, INC. | $1,174.11 | 2021-2022 | |
| Edwards Lifesciences Corporation | $1,133.62 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $966.61 | 2021-2025 | |
| Medtronic, INC. | $701.37 | 2021-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Selectsecure |
| Janssen Pharmaceuticals, INC | $336.82 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $319.06 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $318.39 | 2021-2025 | Lifevest |
| Pfizer INC. | $289.67 | 2019-2025 | |
| Inari Medical, INC. | $285.31 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $221.17 | 2021-2025 | Verquvo |
| Stryker Corporation | $200.29 | 2025 | Artix Mt, Flowtriever, Venacore Thrombectomy Catheter |
| Cook Medical LLC | $156.28 | 2020-2024 | Cook |
| Inspire Medical Systems, INC. | $136.82 | 2025 | Inspire |
| Shockwave Medical, INC | $122.39 | 2025 | |
| Getinge USA Sales, LLC | $117.08 | 2023 | Acrobat-I Stabilizer |
| Alnylam Pharmaceuticals INC. | $84.83 | 2022-2025 | Amvuttra |
| Gilead Sciences, INC. | $72.40 | 2019 | |
| Cardiovascular Systems INC. | $48.24 | 2019 | |
| Novo Nordisk INC | $24.44 | 2025 | Wegovy |
| Abiomed | $20.44 | 2019 | |
| Cvrx, INC. | $19.99 | 2025 | Barostim Neo System |
| Acist Medical Systems, INC. | $14.18 | 2022 | |
| Chiesi USA, INC. | $13.92 | 2022 | |
| Terumo Medical Corporation | $13.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.